The FDA continues to believe the drug approval process represents the best way to help ensure that safe and effective new medicines, including any drugs derived from cannabis, are available to patients in need of appropriate medical therapy. The Agency is committed to supporting the development of new drugs, including cannabis and cannabis-derived drugs, through the investigational new drug and drug approval process.
The FDA is currently evaluating the regulatory frameworks that apply to certain cannabis-derived products that are intended for non-drug uses, including whether and/or how the FDA might consider updating its regulations, as well as whether potential legislation might be appropriate. The information available reveals the need for further study to provide scientific information about the safety and potential uses of CBD.
If you see products making medical claims, please do your research into the company. Medical claims regarding CBD, at this time, are not legal. In my research, those companies are in it for the money and care less about your safety. Your safety is our first concern, and truthfully, over money.
I am pointing this out in my blog because the FDA is raising these safety, marketing and labeling concerns and because we want you to know what we know!
Today’s blog is a summary of what we know to date. As we learn more, our goal is to update you with the information you need to make smart choices about CBD products. Also, as the regulatory pathways are clarified we will take care to notify all Veda Vine Organics members as quickly as possible.
More information is available at: FDA Regulation of Cannabis and Cannabis-Derived Products: Questions and Answers.
Comments